Skip to main content
. 2017 Sep 5;8:222. doi: 10.3389/fendo.2017.00222

Table 2.

Inter-group comparison for men.

Arterial hypertension group (AHG) n = 76 Cushing’s disease (CD) n = 8 Healthy volunteers (HV) n = 24 p-Value Post hoc tests
Age (years), mean ± SD 45.3 ± 9.3 45.0 ± 13.4 41.8 ± 7.7 0.276
HR (bpm), mean ± SD 68.7 ± 9.0 71.3 ± 10.5 65.3 ± 11.4 0.223
Systolic blood pressure (mmHg), mean ± SD 121.6 ± 9.6 132.1 ± 12.9 116.6 ± 9.4 0.0007 AHG vs CD*
HV vs CD#
Diastolic blood pressure (mmHg), mean ± SD 78.3 ± 7.3 84.3 ± 10.1 73.3 ± 8.0 0.001 AHG vs HV*
HV vs CD**
Body mass index (kg/m2), mean ± SD 29.1 ± 3.6 34.1 ± 8.1 26.2 ± 2.4 <0.00001 AHGvs HV**
AHG vs CD**
HV vs CD#
Echocardiography
LVH, n (%) 8 (10.5) 3 (37.5) 3 (12.5) 0.055
LVDD, n (%) 11 (14.5) 4 (50.0) 0 (0.0) 0.008
LVEDD (mm), mean ± SD 49.5 ± 3.1 48.6 ± 2.9 49.8 ± 3.8 0.685
RVEDD (mm), mean ± SD 31.4 ± 2.8 33.4 ± 2.2 30.0 ± 3.0 0.016 HV vs CD*
LA (mm), mean ± SD 38.6 ± 2.6 38.3 ± 3.3 36.8 ± 3.2 0.0004 AHG vs HV*
Left ventricular mass index (g/m2), mean ± SD 91.8 ± 16.5 111.8 ± 20.2 89.0 ± 20.9 0.012 AHG vs CD*
HV vs CD*
LVEF (%), mean ± SD 66.1 ± 3.5 66.6 ± 3.6 67.3 ± 3.3 0.328
GLS (%), mean ± SD −18.8 ± 2.2 −17.2 ± 2.1 −19.6 ± 2.2 0.001 AHG vs CD**
HV vs CD**
E/A (–), mean ± SD 1.18 ± 0.35 0.84 ± 0.20 1.30 ± 0.35 0.008 AHG vs CD*
HV vs CD**
E′ (cm/s), mean ± SD 10.5 ± 2.7 8.3 ± 2.9 12.6 ± 2.4 0.0002 AHG vs HV**
HV vs CD#
E/e′, mean ± SD 6.6 ± 1.6 7.4 ± 1.9 5.9 ± 1.1 0.0495 HV vs CD*

*p < 0.05; **p < 0.01; #p < 0.001.

E/A, mitral flow early (E) and late (A) phase ratio; E/e′, mitral flow early (E) phase and mitral septal annulus early diastolic velocity (e′) ratio; GLS, global longitudinal strain; LA, left atrium diameter; LVDD, left ventricular diastolic dysfunction; LVEDD, left ventricular end diastolic diameter; LVEF, left ventricular ejection fraction; LVH, left ventricular hypertrophy; RVEDD, right ventricular end diastolic diameter.